Catalyst Wire Dossier Catalyst Wire Dossier

Orteronel

Orteronel · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Orteronel, covering 2014-07-23 to 2022-09-08. Get the full timeline:

Most recent: Clinical Trial Update: S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer [Phase 3]

See pricing